LabCorp® and the Texas Association of Community Health Centers Inc. (TACHC) announced that they have entered into an agreement for LabCorp to be the exclusive preferred laboratory for TACHC. This new agreement extends a relationship of more than 25 years and will provide enhanced laboratory services for more than one million patients who receive care from community health centers that are members of TACHC. LabCorp is a leading global life sciences company providing comprehensive laboratory services and end-to-end drug development services. TACHC is a private, non-profit association of approximately 75 community health centers with more than 500 service locations across Texas, which provides necessary health care services to the most vulnerable populations. Under the new agreement, TACHC and LabCorp will use data analytics to identify population health trends, enabling focused community and individual outreach about screening, monitoring and treatment options for common health conditions. TACHC intends to make LabCorp’s Litholink clinical decision support programs available to its members, with the goal of improving the care of patients with chronic kidney disease and/or diabetes. Those programs provide targeted guidance for clinicians and patients about the most appropriate tests, treatments and lifestyle options. This patient-focused information supports better management of those conditions and can help improve patient outcomes and reduce costs.